BCLS I Investco, LP 13D and 13G filings for Marinus Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2021-02-16 3:28 pm Sale |
2020-12-31 | 13G | Marinus Pharmaceuticals, Inc. MRNS |
BCLS I Investco, LP | 1,298,178 3.600% |
-49,553 (-3.68%) |
Filing |